Tecogen (TGEN) Cash & Equivalents (2011 - 2026)

Tecogen (TGEN) has 16 years of Cash & Equivalents data on file, last reported at $9.3 million in Q1 2026.

• Quarterly Cash & Equivalents rose 129.48% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (up 129.48% YoY) and the FY2025 annual result came in at $12.4 million, up 129.97% from the prior year.
• Cash & Equivalents slipped to $9.3 million in Q1 2026, from $12.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $15.3 million in Q3 2025 to a low of $93744.0 in Q4 2022.
• A 5-year average of $4.0 million and a median of $1.9 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 97.41% — and 2024, when it soared 5665.95%.
• Tracing TGEN's Cash & Equivalents over 5 years: stood at $93744.0 in 2022, then changed by 0.0% to $93744.0 in 2023, then soared by 5665.95% to $5.4 million in 2024, then jumped by 129.97% to $12.4 million in 2025, then slipped by 24.92% to $9.3 million in 2026.
• The last three Cash & Equivalents figures came in at $9.3 million (Q1 2026), $12.4 million (Q4 2025), and $15.3 million (Q3 2025), per Business Quant data.